Shell Tianjin Investment Co., Ltd. increased its capital to 600 million US dollars. Tianyancha App shows that recently, Shell Tianjin Investment Co., Ltd. has undergone industrial and commercial changes, and its registered capital has increased from 550 million US dollars to 600 million US dollars. The company was established in September 2018, and its legal representative is Peng Yongdong, which is wholly owned by Hongkong Enjoying International Limited.As of the close of early trading, the Nikkei 225 index fell by 0.65% and the Dongzheng index fell by 0.2%.Sichuan Bank successfully issued 5.4 billion tier-2 capital bonds for the first time, with a subscription multiple of 6.6 times. Sichuan Bank completed its first capital bond issuance on December 10th. According to the information released by China Foreign Exchange Trading Center, the scale of Tier 2 capital bonds issued by Sichuan Bank this time is 5.4 billion yuan, and the subscription multiple is as high as 6.6 times, while that of coupon rate is 2.20%, with a term of 5+5 years. This bond attracted more than 100 institutional investors including banks, brokers, funds, trusts and wealth management subsidiaries to participate in the subscription, with a cumulative investment of more than 35 billion yuan.
The official notification that the hospital canteen was accused of selling spoiled rice: the report lacked sufficient evidence to support it, and the illegal facts of the canteen were not established. On December 11th, the Jiangnan District Market Supervision Administration of Nanning issued a briefing saying that regarding Hou Moumou's complaint about the "selling spoiled rice" in the canteen of the Second People's Hospital of Nanning (West Hospital) on September 9th, 2024, the Jiangnan District Market Supervision Administration sampled and inspected the rice in the canteen warehouse, and the testing institution did so on September 11th. According to the circular, the investigation of the case ended on December 6, 2024, and the Jiangnan District Market Supervision Administration determined that Hou Moumou's report on "selling rotten rice" in the canteen of Nanning Second People's Hospital (West Hospital) lacked sufficient evidence to support it, and the illegal facts of the canteen were not established.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.Xpeng Motors: Tucki P7+ completed the formal delivery of 10,000 Tucki P7+ sets within four weeks after listing.
On the 11th, soybean oil rose by 1.72%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract soybean oil closed at 2,505, up or down by +1.72%, with a turnover of 529,500 lots. The position data showed that the top 20 seats were clear, and the difference position was 59,880 lots. The total contract turnover of soybean oil futures was 685,800 lots, a decrease of 114,300 lots from the previous day. The first 20 seats in the contract held 687,800 lots, an increase of 15,900 lots over the previous day. The short positions in the top 20 seats of the contract were 775,600 lots, an increase of 3,312 lots over the previous day. (Sina Futures)Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee. According to the news of Changzhi News VideoNo. on December 11th, Changzhi held a meeting of leading cadres in the whole city. The meeting announced the decision of the provincial party committee, and Comrade Ding Xiaoqiang was appointed as a member, standing committee member and secretary of Changzhi Municipal Committee.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.
Strategy guide 12-13
Strategy guide 12-13